Seattle Children’s Groundbreaking Research to Help Diagnose Rare Health Condition

Kawasaki Disease

Patranya Bhoolsuwan reporting for KIRO 7 on Kawasaki disease, a rare inflammatory condition that mostly affects children under 5. A Seattle Children’s Hospital team has conducted a clinical trial in 200 patients and reported an improved outcome. The team, led by pediatric cardiologist Dr. Michael Portman, has received $3.5 million from the National Institutes of Health (NIH) to perform genetic studies in nearly 800 patients. Dr. Portman and team are on a mission to study and address Kawasaki disease. His team hopes to create a blood test that could help better identify patients with this disease. Portman notes “most patients with Kawasaki disease do very well” but that “its about 20% that do have significant problems, especially with coronary artery that can be persistent throughout life.”

Television channel KIRO 7 spoke with a couple different children about their experience with the disease including one young girl that took part in Dr. Portman’s clinical trial at Seattle Children’s Hospital.

Lead Research/Investigator

Dr. Michael Portman